Glutathione for Peripheral neuropathy
The relationship between Glutathione and Peripheral neuropathy is somewhat weak. Glutathione ranks 26 of 280 Peripheral neuropathy treatments on our list.
Peripheral neuropathy is damage to nerves of the peripheral nervous system, which may be caused either by diseases of or trauma to the nerve or the side effects of systemic illness. Glutathione (GSH) is a tripeptide with a gamma peptide linkage between the amine group of cysteine (which is attached by normal peptide linkage to a glycine) and the carboxyl group of the glutamate side-chain.
Strength of evidence
Glutathione for Peripheral neuropathy ranks in the bottom 46% of condition-treatment relationships we have analyzed. (The higher the number, the stronger the evidence.)
Of research analyzed, we found 1 study on people and 59 studies on animals. Importantly, we found 0 studies that were randomized and controlled. Such studies are considered the most rigorous, and help to establish or disprove a cause-and-effect relationship between prospective treatments and conditions. So such studies may be needed.
Here's how Glutathione compares to other Peripheral neuropathy treatments we analyzed, as well as to all condition-treatment relationships:
The relationship between Peripheral neuropathy and Glutathione has been little researched. We found at least 212 research articles on the topic. This places the volume of research in the bottom 18% of relationships we have analyzed between treatments and conditions. The pace of research appears to be increasing:
Important caveat—help improve this information
Please note that our analysis is automated and imperfect. If you have personal insight, please help improve our analysis by rating this relationship and the research supporting it. And check back regularly; we last analyzed research for this relationship on Mar 5, 2014, and are constantly updating our database and algorithms.